PPD Recognized for Leadership in Employee Training and Development

Published: 02/25/2020
WILMINGTON, N.C. (February 25, 2020) – PPD, Inc. (Nasdaq:PPD), has been named to Training magazine’s 2020 Training Top 125 list, recognizing organizations that excel at employee training and development. “PPD empowers our greatest asset, our talented and committed employees, to achieve a culture of high performance that enables exceptional service delivery for our pharmaceutical and biotech customers,” said Jay Dixon, senior vice president of quality and enterprise learning at PPD. “Our strategic approach focuses on providing learning and development programs to foster a top-tier learning culture, exemplified by employee growth and achievement.” 2020 marks the ninth consecutive year PPD has been named to the magazine’s list of top 125 businesses. The Training Top 125 list is decided by assessing a range of qualitative and quantitative factors, including investment in employee development, the scope of development programs, how closely such development efforts are linked to business goals and objectives, and the results they achieve. Alisha Talley, principal learning specialist at PPD, also was honored by Training magazine as a winner of the Emerging Training Leaders Awards, which recognize training professionals with two to 10 years of industry experience whose leadership skills, business savvy and training instincts are driving change and innovation in their organizations. PPD and Talley were recognized Feb. 24 during the Training 2020 Conference & Expo at Disney’s Coronado Springs Resort in Orlando, Florida. “The 2020 Training Top 125 winners demonstrate the magic that happens when organizations tie training to specific, measurable strategic goals, leading to the behavior change, business impact and employee engagement that drive success,” said Lorri Freifeld, editor-in-chief of Training magazine. “We salute these best-in-class organizations for their ardent dedication to continuous employee learning and development and their investment in innovative ways to deliver on their commitment.” About PPD PPD (Nasdaq:PPD), is a leading global contract research organization providing comprehensive, integrated drug development, laboratory and lifecycle management services. Our customers include pharmaceutical, biotechnology, medical device, academic and government organizations. With offices in 46 countries and approximately 23,000 professionals worldwide, PPD applies innovative technologies, therapeutic expertise and a firm commitment to quality to help customers bend the cost and time curve of drug development and optimize value in delivering life-changing therapies to improve health. For more information, visit www.ppdi.com. PPD Contacts Media: Holly Devine +1 919 456 6389 holly.devine@ppdi.com Investors: +1 910 558 2899 investors@ppdi.com